| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 1 | 0 | 1 | Apoptosis agonist | 0.924 0.005 DB04456 0.762 0.021 DBMET02875 0.869 0.009 DBMET02874 | ||
| 1 | 0 | 1 | Immunosuppressant | |||
| 0.993 | 0.003 | 0.993 | Analgesic | |||
| 0.988 | 0.003 | 0.988 | Antiinflammatory | |||
| 0.606 | 0.016 | 0.919 | Angiogenesis inhibitor | 0.919 0.004 DB04456 | DB04456 | |
| 0.533 | 0.018 | 0.555 | GABA C receptor rho-3 antagonist | 0.555 0.014 DB04456 0.399 0.062 DBMET02875 0.497 0.027 DBMET02872 0.399 0.062 DBMET02874 | DB04456 | |
| 0.486 | 0.005 | 0.569 | Alpha-N-acetylglucosaminidase inhibitor | 0.569 0.004 DB04456 0.353 0.012 DBMET02875 0.472 0.006 DBMET02872 0.353 0.012 DBMET02874 | DB04456 | |
| 0.466 | 0.051 | 0.48 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.48 0.044 DB04456 0.351 0.15 DBMET02875 0.431 0.075 DBMET02872 0.351 0.15 DBMET02874 | DB04456 | |
| 0.377 | 0.006 | 0.454 | GABA C receptor agonist | 0.454 0.004 DB04456 0.259 0.013 DBMET02875 0.365 0.006 DBMET02872 0.259 0.013 DBMET02874 | DB04456 | |
| 0.387 | 0.048 | 0.448 | 5 Hydroxytryptamine release stimulant | 0.448 0.036 DB04456 0.187 0.133 DBMET02875 0.315 0.065 DBMET02872 0.187 0.133 DBMET02874 | DB04456 | |
| 0.351 | 0.028 | 0.423 | Peroxidase inhibitor | 0.423 0.018 DB04456 0.188 0.063 DBMET02875 0.33 0.032 DBMET02872 0.188 0.063 DBMET02874 | DB04456 | |
| 0.338 | 0.029 | 0.366 | 5 Hydroxytryptamine uptake stimulant | 0.366 0.021 DB04456 0.238 0.093 DBMET02875 0.307 0.041 DBMET02872 0.238 0.093 DBMET02874 | DB04456 | |
| 0.321 | 0.024 | 0.351 | Tyrosine 3 hydroxylase inhibitor | 0.351 0.016 DB04456 0.254 0.064 DBMET02875 0.308 0.029 DBMET02872 0.254 0.064 DBMET02874 | DB04456 | |
| 0.382 | 0.09 | 0.424 | 5 Hydroxytryptamine release inhibitor | 0.424 0.064 DB04456 0.261 0.213 DBMET02875 0.355 0.111 DBMET02872 0.261 0.213 DBMET02874 | DB04456 | |
| 0.297 | 0.008 | 0.339 | Ferrochelatase inhibitor | 0.339 0.005 DB04456 0.196 0.023 DBMET02875 0.279 0.009 DBMET02872 0.196 0.023 DBMET02874 | DB04456 | |
| 0.343 | 0.056 | 0.476 | Aldehyde oxidase inhibitor | 0.476 0.036 DB04456 0.175 0.119 DBMET02875 0.311 0.063 DBMET02872 0.175 0.119 DBMET02874 | DB04456 | |
| 0.249 | 0.023 | 0.28 | Succinate dehydrogenase inhibitor | 0.28 0.014 DB04456 0.204 0.046 DBMET02875 0.244 0.024 DBMET02872 0.204 0.046 DBMET02874 | DB04456 | |
| 0.243 | 0.019 | 0.243 | 5 Hydroxytryptamine 3E antagonist | 0.243 0.019 DB04456 0.19 0.082 DBMET02875 0.22 0.036 DBMET02872 0.19 0.082 DBMET02874 | ||
| 0.299 | 0.092 | 0.324 | Calcium channel activator | 0.324 0.07 DB04456 0.268 0.126 DBMET02872 | DB04456 | |
| 0.243 | 0.038 | 0.259 | Nitric-oxide synthase stimulant | 0.259 0.027 DB04456 0.188 0.11 DBMET02875 0.229 0.05 DBMET02872 0.188 0.11 DBMET02874 | DB04456 | |
| 0.22 | 0.016 | 0.27 | UDP-glucose 4-epimerase inhibitor | 0.27 0.012 DB04456 0.145 0.03 DBMET02875 0.205 0.017 DBMET02872 0.145 0.03 DBMET02874 | DB04456 | |
| 0.21 | 0.024 | 0.226 | GABA C receptor rho-2 antagonist | 0.226 0.018 DB04456 0.147 0.078 DBMET02875 0.191 0.034 DBMET02872 0.147 0.078 DBMET02874 | DB04456 | |
| 0.191 | 0.012 | 0.236 | Triose-phosphate isomerase inhibitor | 0.236 0.008 DB04456 0.135 0.025 DBMET02875 0.183 0.013 DBMET02872 0.135 0.025 DBMET02874 | DB04456 | |
| 0.195 | 0.016 | 0.233 | Adenylate kinase inhibitor | 0.233 0.011 DB04456 0.138 0.032 DBMET02875 0.186 0.017 DBMET02872 0.138 0.032 DBMET02874 | DB04456 | |
| 0.335 | 0.159 | 0.382 | Caspase 9 stimulant | 0.382 0.122 DB04456 0.301 0.193 DBMET02872 | DB04456 | |
| 0.246 | 0.077 | 0.291 | Superoxide dismutase inhibitor | 0.291 0.054 DB04456 0.227 0.092 DBMET02872 | DB04456 | |
| 0.176 | 0.007 | 0.263 | Biliverdin reductase inhibitor | 0.263 0.004 DB04456 0.194 0.006 DBMET02875 0.263 0.004 DBMET02872 0.243 0.004 DBMET02874 | DBMET02872 | |
| 0.184 | 0.016 | 0.22 | GABA C receptor antagonist | 0.22 0.009 DB04456 0.127 0.046 DBMET02875 0.175 0.019 DBMET02872 0.127 0.046 DBMET02874 | DB04456 | |
| 0.176 | 0.009 | 0.184 | Ca2+-transporting ATPase inhibitor | 0.184 0.005 DB04456 0.159 0.025 DBMET02875 0.173 0.01 DBMET02872 0.159 0.025 DBMET02874 | DB04456 | |
| 0.178 | 0.013 | 0.21 | NADH dehydrogenase inhibitor | 0.21 0.01 DB04456 0.13 0.024 DBMET02875 0.169 0.014 DBMET02872 0.13 0.024 DBMET02874 | DB04456 | |
| 0.196 | 0.036 | 0.207 | Arachidonic acid antagonist | 0.207 0.026 DB04456 0.16 0.076 DBMET02875 0.192 0.041 DBMET02872 0.16 0.076 DBMET02874 | DB04456 | |
| 0.177 | 0.02 | 0.218 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.218 0.013 DB04456 0.109 0.046 DBMET02875 0.164 0.023 DBMET02872 0.109 0.046 DBMET02874 | DB04456 | |
| 0.224 | 0.069 | 0.25 | RNA-directed DNA polymerase inhibitor | 0.25 0.049 DB04456 0.212 0.083 DBMET02872 | DB04456 | |
| 0.171 | 0.016 | 0.22 | Porphobilinogen synthase inhibitor | 0.22 0.01 DB04456 0.097 0.037 DBMET02875 0.159 0.019 DBMET02872 0.097 0.037 DBMET02874 | DB04456 | |
| 0.163 | 0.016 | 0.191 | GABA C receptor rho-1 antagonist | 0.191 0.009 DB04456 0.111 0.048 DBMET02875 0.154 0.02 DBMET02872 0.111 0.048 DBMET02874 | DB04456 | |
| 0.152 | 0.01 | 0.217 | Alcohol oxidase inhibitor | 0.217 0.006 DB04456 0.084 0.023 DBMET02875 0.143 0.011 DBMET02872 0.084 0.023 DBMET02874 | DB04456 | |
| 0.159 | 0.016 | 0.187 | Phosphofructokinase-1 inhibitor | 0.187 0.012 DB04456 0.112 0.027 DBMET02875 0.154 0.017 DBMET02872 0.112 0.027 DBMET02874 | DB04456 | |
| 0.15 | 0.011 | 0.179 | Carbamoyl phosphate synthetase inhibitor | 0.179 0.009 DB04456 0.109 0.018 DBMET02875 0.145 0.012 DBMET02872 0.109 0.018 DBMET02874 | DB04456 | |
| 0.158 | 0.021 | 0.187 | Creatine kinase inhibitor | 0.187 0.013 DB04456 0.112 0.048 DBMET02875 0.152 0.023 DBMET02872 0.112 0.048 DBMET02874 | DB04456 | |
| 0.166 | 0.039 | 0.18 | Adenylate cyclase stimulant | 0.18 0.026 DB04456 0.133 0.096 DBMET02875 0.161 0.046 DBMET02872 0.133 0.096 DBMET02874 | DB04456 | |
| 0.135 | 0.01 | 0.16 | Acyl-CoA dehydrogenase inhibitor | 0.16 0.008 DB04456 0.085 0.02 DBMET02875 0.124 0.012 DBMET02872 0.085 0.02 DBMET02874 | DB04456 | |
| 0.133 | 0.013 | 0.133 | Thioredoxin reductase inhibitor | 0.093 0.036 DBMET02872 | ||
| 0.141 | 0.026 | 0.158 | DOPA decarboxylase inhibitor | 0.158 0.017 DB04456 0.11 0.059 DBMET02875 0.137 0.029 DBMET02872 0.11 0.059 DBMET02874 | DB04456 | |
| 0.215 | 0.101 | 0.243 | DNA synthesis inhibitor | 0.243 0.071 DB04456 0.204 0.117 DBMET02872 | DB04456 | |
| 0.15 | 0.041 | 0.186 | Cystathionine beta-synthase inhibitor | 0.186 0.028 DB04456 0.098 0.079 DBMET02875 0.142 0.044 DBMET02872 0.098 0.079 DBMET02874 | DB04456 | |
| 0.127 | 0.021 | 0.155 | Glutamate dehydrogenase inhibitor | 0.155 0.015 DB04456 0.09 0.037 DBMET02875 0.122 0.022 DBMET02872 0.09 0.037 DBMET02874 | DB04456 | |
| 0.144 | 0.039 | 0.154 | 5 Hydroxytryptamine 3A agonist | 0.154 0.033 DB04456 0.113 0.062 DBMET02872 | DB04456 | |
| 0.186 | 0.085 | 0.218 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.218 0.059 DB04456 0.173 0.103 DBMET02872 | DB04456 | |
| 0.12 | 0.021 | 0.146 | Glutamate decarboxylase inhibitor | 0.146 0.014 DB04456 0.086 0.039 DBMET02875 0.116 0.022 DBMET02872 0.086 0.039 DBMET02874 | DB04456 | |
| 0.223 | 0.125 | 0.252 | Insulysin inhibitor | 0.252 0.095 DB04456 0.204 0.15 DBMET02872 | DB04456 | |
| 0.109 | 0.013 | 0.13 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.13 0.01 DB04456 0.075 0.023 DBMET02875 0.103 0.014 DBMET02872 0.075 0.023 DBMET02874 | DB04456 | |
| 0.138 | 0.043 | 0.159 | Aminopeptidase B inhibitor | 0.159 0.034 DB04456 0.09 0.073 DBMET02875 0.132 0.046 DBMET02872 0.09 0.073 DBMET02874 | DB04456 | |
| 0.113 | 0.021 | 0.121 | Granulocyte macrophage colony stimulating factor agonist | 0.121 0.015 DB04456 0.084 0.064 DBMET02875 0.104 0.029 DBMET02872 0.084 0.064 DBMET02874 | DB04456 | |
| 0.099 | 0.009 | 0.123 | Aconitate hydratase inhibitor | 0.123 0.005 DB04456 0.071 0.018 DBMET02875 0.096 0.009 DBMET02872 0.071 0.018 DBMET02874 | DB04456 | |
| 0.125 | 0.035 | 0.135 | Anabolic | 0.135 0.027 DB04456 0.096 0.068 DBMET02875 0.12 0.04 DBMET02872 0.096 0.068 DBMET02874 | DB04456 | |
| 0.122 | 0.035 | 0.141 | Electrolyte absorption antagonist | 0.141 0.023 DB04456 0.11 0.045 DBMET02872 | DB04456 | |
| 0.091 | 0.006 | 0.103 | Glucose-6-phosphate isomerase inhibitor | 0.103 0.005 DB04456 0.073 0.011 DBMET02875 0.089 0.007 DBMET02872 0.073 0.011 DBMET02874 | DB04456 | |
| 0.102 | 0.019 | 0.131 | Argininosuccinate synthase inhibitor | 0.131 0.014 DB04456 0.063 0.034 DBMET02875 0.096 0.02 DBMET02872 0.063 0.034 DBMET02874 | DB04456 | |
| 0.148 | 0.066 | 0.174 | Mannose-6-phosphate isomerase inhibitor | 0.174 0.046 DB04456 0.131 0.084 DBMET02872 | DB04456 | |
| 0.106 | 0.025 | 0.122 | Aminopeptidase I inhibitor | 0.122 0.019 DB04456 0.079 0.043 DBMET02875 0.102 0.027 DBMET02872 0.079 0.043 DBMET02874 | DB04456 | |
| 0.241 | 0.162 | 0.313 | Histamine release inhibitor | 0.313 0.117 DB04456 0.212 0.189 DBMET02872 | DB04456 | |
| 0.222 | 0.146 | 0.275 | Cholesterol antagonist | 0.275 0.108 DB04456 0.199 0.166 DBMET02872 | DB04456 | |
| 0.116 | 0.041 | 0.135 | Prolactin inhibitor | 0.135 0.029 DB04456 0.104 0.051 DBMET02872 | DB04456 | |
| 0.197 | 0.123 | 0.233 | Interleukin agonist | 0.233 0.092 DB04456 0.17 0.149 DBMET02872 | DB04456 | |
| 0.088 | 0.017 | 0.099 | Glutamate (mGluR6) antagonist | 0.099 0.011 DB04456 0.07 0.04 DBMET02875 0.086 0.019 DBMET02872 0.07 0.04 DBMET02874 | DB04456 | |
| 0.098 | 0.027 | 0.126 | Phenylalanine 4-hydroxylase inhibitor | 0.126 0.017 DB04456 0.061 0.057 DBMET02875 0.093 0.029 DBMET02872 0.061 0.057 DBMET02874 | DB04456 | |
| 0.091 | 0.021 | 0.095 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.095 0.017 DB04456 0.084 0.03 DBMET02872 | DB04456 | |
| 0.174 | 0.105 | 0.199 | Neurotrophic factor enhancer | 0.199 0.078 DB04456 0.16 0.124 DBMET02872 | DB04456 | |
| 0.085 | 0.019 | 0.088 | Exportin-1 inhibitor | 0.088 0.016 DB04456 0.073 0.036 DBMET02872 | DB04456 | |
| 0.095 | 0.031 | 0.104 | Estrogen-related receptor beta agonist | 0.104 0.02 DB04456 0.079 0.071 DBMET02875 0.093 0.035 DBMET02872 0.079 0.071 DBMET02874 | DB04456 | |
| 0.147 | 0.082 | 0.163 | Interferon gamma antagonist | 0.163 0.063 DB04456 0.14 0.092 DBMET02872 | DB04456 | |
| 0.086 | 0.021 | 0.093 | Glutamate (mGluR7) antagonist | 0.093 0.015 DB04456 0.077 0.031 DBMET02872 | DB04456 | |
| 0.146 | 0.083 | 0.162 | CF transmembrane conductance regulator agonist | 0.162 0.058 DB04456 0.134 0.109 DBMET02872 | DB04456 | |
| 0.101 | 0.04 | 0.111 | Glutamate release inhibitor | 0.111 0.029 DB04456 0.091 0.059 DBMET02872 | DB04456 | |
| 0.089 | 0.028 | 0.094 | Vanilloid 4 agonist | 0.094 0.022 DB04456 0.081 0.039 DBMET02872 | DB04456 | |
| 0.204 | 0.143 | 0.231 | Gastrin inhibitor | 0.231 0.104 DB04456 | DB04456 | |
| 0.089 | 0.029 | 0.104 | Glycine receptor agonist | 0.104 0.019 DB04456 0.083 0.035 DBMET02872 | DB04456 | |
| 0.083 | 0.023 | 0.102 | Purinergic P2X1 antagonist | 0.102 0.016 DB04456 0.077 0.027 DBMET02872 | DB04456 | |
| 0.093 | 0.035 | 0.13 | Histidine decarboxylase inhibitor | 0.13 0.023 DB04456 0.085 0.039 DBMET02872 | DB04456 | |
| 0.126 | 0.069 | 0.137 | Cathepsin H inhibitor | 0.137 0.057 DB04456 0.109 0.09 DBMET02872 | DB04456 | |
| 0.094 | 0.038 | 0.104 | D-Ala-D-Ala ligase inhibitor | 0.104 0.025 DB04456 0.091 0.042 DBMET02872 | DB04456 | |
| 0.094 | 0.038 | 0.107 | Glycine receptor antagonist | 0.107 0.027 DB04456 0.085 0.049 DBMET02872 | DB04456 | |
| 0.074 | 0.024 | 0.09 | Ornithine carbamoyltransferase inhibitor | 0.09 0.018 DB04456 0.051 0.038 DBMET02875 0.071 0.025 DBMET02872 0.051 0.038 DBMET02874 | DB04456 | |
| 0.09 | 0.041 | 0.099 | Na+ K+ transporting ATPase inhibitor | 0.099 0.033 DB04456 0.086 0.045 DBMET02872 | DB04456 | |
| 0.114 | 0.065 | 0.128 | Photosensitizer | 0.128 0.048 DB04456 0.105 0.08 DBMET02872 | DB04456 | |
| 0.06 | 0.012 | 0.073 | Dopamine D5 agonist | 0.073 0.008 DB04456 0.04 0.028 DBMET02875 0.057 0.013 DBMET02872 0.04 0.028 DBMET02874 | DB04456 | |
| 0.151 | 0.104 | 0.17 | Phospholipase C inhibitor | 0.17 0.073 DB04456 0.145 0.117 DBMET02872 | DB04456 | |
| 0.081 | 0.034 | 0.088 | Phospholipase D inhibitor | 0.088 0.024 DB04456 0.073 0.048 DBMET02872 | DB04456 | |
| 0.189 | 0.144 | 0.204 | 5 Hydroxytryptamine 1E antagonist | 0.204 0.127 DB04456 | DB04456 | |
| 0.056 | 0.011 | 0.072 | Fumarate hydratase inhibitor | 0.072 0.008 DB04456 0.038 0.02 DBMET02875 0.054 0.012 DBMET02872 0.038 0.02 DBMET02874 | DB04456 | |
| 0.065 | 0.021 | 0.075 | Alpha-mannosidase inhibitor | 0.075 0.014 DB04456 0.049 0.046 DBMET02875 0.063 0.023 DBMET02872 0.049 0.046 DBMET02874 | DB04456 | |
| 0.055 | 0.01 | 0.063 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.063 0.006 DB04456 0.043 0.026 DBMET02875 0.053 0.012 DBMET02872 0.043 0.026 DBMET02874 | DB04456 | |
| 0.054 | 0.009 | 0.062 | Glutamate (mGluR8) agonist | 0.062 0.006 DB04456 0.04 0.022 DBMET02875 0.052 0.011 DBMET02872 0.04 0.022 DBMET02874 | DB04456 | |
| 0.098 | 0.056 | 0.124 | HIV-1 integrase (Overall Integration) inhibitor | 0.124 0.037 DB04456 0.089 0.066 DBMET02872 | DB04456 | |
| 0.056 | 0.015 | 0.063 | Guanylate cyclase inhibitor | 0.063 0.009 DB04456 0.052 0.019 DBMET02872 | DB04456 | |
| 0.063 | 0.024 | 0.069 | Pregnane X receptor antagonist | 0.069 0.016 DB04456 0.059 0.033 DBMET02872 | DB04456 | |
| 0.1 | 0.06 | 0.106 | Glutamate (mGluR7) agonist | 0.106 0.049 DB04456 | DB04456 | |
| 0.051 | 0.012 | 0.058 | Kainate receptor agonist | 0.058 0.008 DB04456 0.04 0.032 DBMET02875 0.05 0.014 DBMET02872 0.04 0.032 DBMET02874 | DB04456 | |
| 0.081 | 0.042 | 0.088 | MAP kinase kinase 7 inhibitor | 0.088 0.027 DB04456 0.078 0.051 DBMET02872 | DB04456 | |
| 0.147 | 0.109 | 0.16 | Neurotensin receptor agonist | 0.16 0.079 DB04456 0.138 0.133 DBMET02872 | DB04456 | |
| 0.101 | 0.065 | 0.118 | Carbonic anhydrase XV inhibitor | 0.118 0.048 DB04456 0.093 0.078 DBMET02872 | DB04456 | |
| 0.051 | 0.016 | 0.057 | Alpha 1d adrenoreceptor agonist | 0.057 0.012 DB04456 0.04 0.026 DBMET02872 | DB04456 | |
| 0.096 | 0.062 | 0.11 | Lanosterol 14 alpha demethylase inhibitor | 0.11 0.041 DB04456 | DB04456 | |
| 0.134 | 0.101 | 0.142 | Heat shock protein 70 antagonist | 0.142 0.068 DB04456 | DB04456 | |
| 0.084 | 0.051 | 0.09 | CC chemokine 5 receptor agonist | 0.09 0.038 DB04456 0.078 0.071 DBMET02872 | DB04456 | |
| 0.08 | 0.047 | 0.119 | Catalase inhibitor | 0.119 0.033 DB04456 0.073 0.052 DBMET02872 | DB04456 | |
| 0.089 | 0.057 | 0.1 | Histamine N-methyltransferase inhibitor | 0.1 0.046 DB04456 | DB04456 | |
| 0.054 | 0.022 | 0.066 | Adenylate cyclase 1 inhibitor | 0.066 0.014 DB04456 0.046 0.032 DBMET02872 | DB04456 | |
| 0.131 | 0.099 | 0.15 | Sphingosine 1-phosphate receptor 5 antagonist | 0.15 0.062 DB04456 0.122 0.12 DBMET02872 | DB04456 | |
| 0.038 | 0.008 | 0.042 | Purinergic P2Y15 antagonist | 0.042 0.006 DB04456 0.029 0.019 DBMET02875 0.037 0.009 DBMET02872 0.029 0.019 DBMET02874 | DB04456 | |
| 0.06 | 0.03 | 0.069 | Dihydroorotate oxidase inhibitor | 0.069 0.018 DB04456 0.057 0.034 DBMET02872 | DB04456 | |
| 0.052 | 0.023 | 0.063 | Mannosidase inhibitor | 0.063 0.015 DB04456 0.05 0.025 DBMET02872 | DB04456 | |
| 0.048 | 0.021 | 0.048 | Histamine H1 receptor agonist | 0.048 0.021 DB04456 0.041 0.036 DBMET02872 | ||
| 0.085 | 0.057 | 0.092 | mTOR complex 2 inhibitor | 0.092 0.044 DB04456 | DB04456 | |
| 0.077 | 0.049 | 0.087 | GABA B receptor agonist | 0.087 0.029 DB04456 0.073 0.058 DBMET02872 | DB04456 | |
| 0.107 | 0.079 | 0.12 | Microtubule formation inhibitor | 0.12 0.06 DB04456 0.098 0.094 DBMET02872 | DB04456 | |
| 0.081 | 0.055 | 0.145 | Carbonic anhydrase VI inhibitor | 0.145 0.022 DB04456 0.088 0.048 DBMET02875 0.145 0.022 DBMET02872 0.124 0.028 DBMET02874 | DBMET02872 | |
| 0.049 | 0.023 | 0.049 | Histamine H2 receptor agonist | 0.049 0.022 DB04456 | ||
| 0.12 | 0.096 | 0.136 | Sphingosine 1-phosphate receptor 2 antagonist | 0.136 0.062 DB04456 | DB04456 | |
| 0.103 | 0.08 | 0.11 | Acetylcholine release stimulant | 0.11 0.066 DB04456 | DB04456 | |
| 0.057 | 0.033 | 0.061 | Immunoglobulin Fc receptor antagonist | 0.061 0.022 DB04456 0.054 0.042 DBMET02872 | DB04456 | |
| 0.037 | 0.014 | 0.043 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.043 0.011 DB04456 0.034 0.015 DBMET02872 | DB04456 | |
| 0.1 | 0.077 | 0.12 | Mucolytic | 0.12 0.055 DB04456 0.094 0.087 DBMET02872 | DB04456 | |
| 0.03 | 0.009 | 0.033 | Vanilloid 2 agonist | 0.033 0.007 DB04456 0.029 0.012 DBMET02872 | DB04456 | |
| 0.074 | 0.054 | 0.088 | GABA aminotransferase inhibitor | 0.088 0.037 DB04456 0.069 0.063 DBMET02872 | DB04456 | |
| 0.131 | 0.111 | 0.147 | Melanin inhibitor | 0.147 0.086 DB04456 0.126 0.121 DBMET02872 | DB04456 | |
| 0.05 | 0.03 | 0.055 | Dopamine beta hydroxylase inhibitor | 0.055 0.021 DB04456 0.046 0.041 DBMET02872 | DB04456 | |
| 0.14 | 0.12 | 0.152 | 3C-like protease (Human coronavirus) inhibitor | 0.152 0.098 DB04456 | DB04456 | |
| 0.059 | 0.04 | 0.064 | Ryanodine receptor antagonist | 0.064 0.027 DB04456 0.055 0.053 DBMET02872 | DB04456 | |
| 0.142 | 0.123 | 0.182 | Anesthetic general | 0.182 0.085 DB04456 | DB04456 | |
| 0.024 | 0.006 | 0.028 | Carbonic anhydrase VIII inhibitor | 0.028 0.005 DB04456 0.021 0.007 DBMET02872 | DB04456 | |
| 0.024 | 0.006 | 0.028 | Carbonic anhydrase X inhibitor | 0.028 0.005 DB04456 0.021 0.007 DBMET02872 | DB04456 | |
| 0.066 | 0.048 | 0.07 | Acetylcholine M5 receptor agonist | 0.07 0.044 DB04456 | DB04456 | |
| 0.052 | 0.033 | 0.06 | Lysophosphatidic acid 3 receptor antagonist | 0.06 0.023 DB04456 0.049 0.037 DBMET02872 | DB04456 | |
| 0.063 | 0.046 | 0.066 | Transcription factor RelA inhibitor | 0.066 0.038 DB04456 | DB04456 | |
| 0.041 | 0.025 | 0.047 | Membrane dipeptidase inhibitor | 0.047 0.018 DB04456 0.039 0.027 DBMET02872 | DB04456 | |
| 0.108 | 0.092 | 0.126 | Cyclooxygenase 3 inhibitor | 0.126 0.071 DB04456 | DB04456 | |
| 0.044 | 0.028 | 0.05 | Oxytocin agonist | 0.05 0.024 DB04456 0.039 0.033 DBMET02872 | DB04456 | |
| 0.072 | 0.057 | 0.078 | CYP2A6 inhibitor | 0.078 0.05 DB04456 | DB04456 | |
| 0.073 | 0.059 | 0.087 | Keratolytic | 0.087 0.041 DB04456 0.07 0.065 DBMET02872 | DB04456 | |
| 0.021 | 0.007 | 0.023 | Telomerase stimulant | 0.023 0.005 DB04456 0.016 0.014 DBMET02875 0.02 0.007 DBMET02872 0.016 0.014 DBMET02874 | DB04456 | |
| 0.029 | 0.015 | 0.032 | Hedgehog signaling activator | 0.032 0.01 DB04456 0.027 0.019 DBMET02872 | DB04456 | |
| 0.043 | 0.029 | 0.048 | Nerve growth factor antagonist | 0.048 0.02 DB04456 | DB04456 | |
| 0.027 | 0.014 | 0.028 | Complement factor 1s inhibitor | 0.028 0.012 DB04456 | DB04456 | |
| 0.044 | 0.031 | 0.055 | Geranyltranstransferase inhibitor | 0.055 0.018 DB04456 0.041 0.035 DBMET02872 | DB04456 | |
| 0.031 | 0.019 | 0.032 | Nicotinic alpha3beta4 receptor agonist | 0.032 0.017 DB04456 | DB04456 | |
| 0.033 | 0.021 | 0.037 | Glutamate (mGluR3) agonist | 0.037 0.013 DB04456 0.032 0.023 DBMET02872 | DB04456 | |
| 0.02 | 0.008 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 DB04456 0.02 0.009 DBMET02872 | DB04456 | |
| 0.026 | 0.015 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 DB04456 0.025 0.017 DBMET02872 | DB04456 | |
| 0.099 | 0.088 | 0.117 | Cholesterol synthesis inhibitor | 0.117 0.068 DB04456 | DB04456 | |
| 0.042 | 0.032 | 0.044 | Heme oxygenase inhibitor | 0.044 0.025 DB04456 | DB04456 | |
| 0.051 | 0.041 | 0.063 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.063 0.027 DB04456 0.048 0.046 DBMET02872 | DB04456 | |
| 0.024 | 0.014 | 0.029 | Glutamate (mGluR1a) agonist | 0.029 0.009 DB04456 0.02 0.019 DBMET02872 | DB04456 | |
| 0.029 | 0.019 | 0.032 | Estrogen-related receptor gamma antagonist | 0.032 0.012 DB04456 0.028 0.022 DBMET02872 | DB04456 | |
| 0.048 | 0.039 | 0.052 | Squalene epoxidase inhibitor | 0.052 0.031 DB04456 | DB04456 | |
| 0.105 | 0.096 | 0.127 | Toll-Like receptor 2 antagonist | 0.127 0.07 DB04456 | DB04456 | |
| 0.028 | 0.02 | 0.037 | Uridine phosphorylase inhibitor | 0.037 0.013 DB04456 0.025 0.023 DBMET02872 | DB04456 | |
| 0.06 | 0.052 | 0.063 | Protease 3C (Human rhinovirus) inhibitor | 0.063 0.047 DB04456 | DB04456 | |
| 0.015 | 0.008 | 0.019 | Lysophosphatidic acid receptor 3 agonist | 0.019 0.006 DB04456 0.014 0.009 DBMET02872 | DB04456 | |
| 0.037 | 0.031 | 0.046 | GABA uptake inhibitor | 0.046 0.019 DB04456 | DB04456 | |
| 0.016 | 0.01 | 0.018 | Purinergic P2Y1 agonist | 0.018 0.008 DB04456 0.016 0.011 DBMET02872 | DB04456 | |
| 0.088 | 0.083 | 0.103 | Falcipain 3 inhibitor | 0.103 0.067 DB04456 | DB04456 | |
| 0.085 | 0.08 | 0.104 | Sphingomyelinase inhibitor | 0.104 0.056 DB04456 | DB04456 | |
| 0.061 | 0.056 | 0.064 | Calcium channel P-type blocker | 0.064 0.042 DB04456 | DB04456 | |
| 0.123 | 0.119 | 0.133 | Pregnane X receptor agonist | 0.133 0.091 DB04456 | DB04456 | |
| 0.013 | 0.009 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.016 0.005 DB04456 0.013 0.01 DBMET02872 | DB04456 | |
| 0.025 | 0.021 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.03 0.013 DB04456 | DB04456 | |
| 0.012 | 0.009 | 0.015 | Glutamate (mGluR6) agonist | 0.015 0.006 DB04456 0.011 0.009 DBMET02872 | DB04456 | |
| 0.015 | 0.012 | 0.018 | Thromboxane A2 agonist | 0.018 0.008 DB04456 | DB04456 | |
| 0.012 | 0.01 | 0.013 | Carbonic anhydrase XI inhibitor | 0.013 0.008 DB04456 | DB04456 | |
| 0.018 | 0.016 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.011 DB04456 | DB04456 | |
| 0.031 | 0.03 | 0.041 | Arginase inhibitor | 0.041 0.021 DB04456 | DB04456 | |
| 0.111 | 0.111 | 0.122 | Vanilloid 1 agonist | 0.122 0.084 DB04456 | DB04456 | |
| 0.084 | 0.084 | 0.103 | Carbonic anhydrase III inhibitor | 0.103 0.059 DB04456 | DB04456 | |
| 0.04 | 0.04 | 0.052 | Adenosine deaminase inhibitor | 0.052 0.028 DB04456 | DB04456 | |
| 0.019 | 0.02 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 DB04456 | DB04456 | |
| 0.023 | 0.024 | 0.028 | Lysine carboxypeptidase inhibitor | 0.028 0.018 DB04456 | DB04456 | |
| 0.025 | 0.026 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.018 DB04456 | DB04456 | |
| 0.006 | 0.008 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DB04456 | DB04456 | |
| 0.02 | 0.022 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 DB04456 | DB04456 | |
| 0.019 | 0.02 | 0.021 | Retinoid X beta receptor antagonist | 0.021 0.013 DB04456 | DB04456 | |
| 0.039 | 0.041 | 0.045 | AICAR transformylase inhibitor | 0.045 0.028 DB04456 | DB04456 | |
| 0.024 | 0.027 | 0.026 | Nicotinic alpha4beta2 receptor agonist | 0.026 0.023 DB04456 | DB04456 | |
| 0.051 | 0.053 | 0.059 | Carbonic anhydrase stimulant | 0.059 0.042 DB04456 | DB04456 | |
| 0.023 | 0.026 | 0.026 | Thymidine phosphorylase inhibitor | 0.026 0.018 DB04456 | DB04456 | |
| 0.019 | 0.023 | 0.022 | Prostaglandin F2 alpha agonist | 0.022 0.016 DB04456 | DB04456 | |
| 0.018 | 0.023 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 DB04456 | DB04456 | |
| 0.029 | 0.033 | 0.036 | Phosphoglycerate kinase inhibitor | 0.036 0.023 DB04456 | DB04456 | |
| 0.044 | 0.049 | 0.047 | Cytokine production stimulant | 0.047 0.036 DB04456 | DB04456 | |
| 0.055 | 0.06 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.051 DB04456 | DB04456 | |
| 0.051 | 0.056 | 0.069 | NMDA receptor glycine site agonist | 0.069 0.037 DB04456 | DB04456 | |
| 0.035 | 0.04 | 0.038 | Vanilloid 3 antagonist | 0.038 0.028 DB04456 | DB04456 | |
| 0.035 | 0.041 | 0.041 | Thymidine kinase inhibitor | 0.041 0.029 DB04456 | DB04456 | |
| 0.014 | 0.02 | 0.017 | Nicotinic acid receptor 1 antagonist | 0.017 0.013 DB04456 | DB04456 | |
| 0.047 | 0.054 | 0.057 | Sphingosine kinase 2 inhibitor | 0.057 0.036 DB04456 | DB04456 | |
| 0.056 | 0.064 | 0.064 | Interferon inducer | 0.064 0.045 DB04456 | DB04456 | |
| 0.066 | 0.075 | 0.07 | Potassium channel (Tandem pore domain) blocker | 0.07 0.063 DB04456 | DB04456 | |
| 0.032 | 0.04 | 0.038 | Dihydropteroate synthase inhibitor | 0.038 0.029 DB04456 | DB04456 | |
| 0.093 | 0.103 | 0.134 | Amylase inhibitor | 0.134 0.073 DB04456 | DB04456 | |
| 0.053 | 0.063 | 0.058 | 5 Hydroxytryptamine 3 agonist | 0.058 0.052 DB04456 | DB04456 | |
| 0.095 | 0.106 | 0.117 | Aldehyde dehydrogenase inhibitor | 0.117 0.074 DB04456 | DB04456 | |
| 0.043 | 0.054 | 0.047 | Potassium channel (Inward rectifier) activator | 0.047 0.041 DB04456 | DB04456 | |
| 0.069 | 0.08 | 0.086 | Ornithine decarboxylase inhibitor | 0.086 0.06 DB04456 | DB04456 | |
| 0.041 | 0.053 | 0.045 | Potassium channel (ATP-sensitive) activator | 0.045 0.04 DB04456 | DB04456 | |
| 0.03 | 0.042 | 0.035 | Toll-Like receptor 2 agonist | 0.035 0.034 DB04456 | DB04456 | |
| 0.02 | 0.033 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.021 DB04456 | DB04456 | |
| 0.028 | 0.042 | 0.032 | Retinoid X alpha receptor antagonist | 0.032 0.027 DB04456 | DB04456 | |
| 0.051 | 0.065 | 0.064 | NMDA receptor agonist | 0.064 0.042 DB04456 | DB04456 | |
| 0.03 | 0.046 | 0.036 | Retinoid X receptor antagonist | 0.036 0.03 DB04456 | DB04456 | |
| 0.028 | 0.044 | 0.036 | Glutamate (mGluR3) antagonist | 0.036 0.027 DB04456 | DB04456 | |
| 0.044 | 0.06 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.047 DB04456 | DB04456 | |
| 0.03 | 0.046 | 0.035 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.027 DB04456 | DB04456 | |
| 0.065 | 0.083 | 0.076 | Interferon agonist | 0.076 0.059 DB04456 | DB04456 | |
| 0.049 | 0.072 | 0.053 | Leukotriene C antagonist | 0.053 0.052 DB04456 | DB04456 | |
| 0.035 | 0.058 | 0.04 | Glutamate (mGluR4) antagonist | 0.04 0.037 DB04456 | DB04456 | |
| 0.036 | 0.06 | 0.222 | Carbonic anhydrase VB inhibitor | 0.222 0.004 DB04456 0.076 0.024 DBMET02872 | DB04456 | |
| 0.059 | 0.084 | 0.065 | MDM2 inhibitor | 0.065 0.056 DB04456 | DB04456 | |
| 0.099 | 0.126 | 0.114 | Sphingosine 1-phosphate receptor 4 antagonist | 0.114 0.086 DB04456 | DB04456 | |
| 0.075 | 0.104 | 0.093 | Expectorant | 0.093 0.077 DB04456 | DB04456 | |
| 0.024 | 0.059 | 0.048 | Carbonic anhydrase IV inhibitor | 0.048 0.026 DB04456 0.047 0.027 DBMET02872 0.037 0.036 DBMET02874 | DB04456 | |
| 0.096 | 0.131 | 0.114 | Protein kinase stimulant | 0.114 0.099 DB04456 | DB04456 | |
| 0.052 | 0.089 | 0.067 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.067 0.065 DB04456 | DB04456 | |
| 0.085 | 0.123 | 0.096 | TRPA1 agonist | 0.096 0.095 DB04456 | DB04456 | |
| 0.043 | 0.085 | 0.059 | Sphingosine 1-phosphate receptor 4 agonist | 0.059 0.056 DB04456 | DB04456 | |
| 0.066 | 0.11 | 0.083 | Alcohol dehydrogenase inhibitor | 0.083 0.075 DB04456 | DB04456 | |
| 0.097 | 0.144 | 0.123 | Cell wall synthesis inhibitor | 0.123 0.095 DB04456 | DB04456 | |
| 0.12 | 0.17 | 0.14 | ATPase inhibitor | 0.14 0.12 DB04456 | DB04456 | |
| 0.165 | 0.219 | 0.21 | Vasodilator, coronary | 0.21 0.173 DB04456 | DB04456 | |
| 0.039 | 0.093 | 0.204 | Carbonic anhydrase V inhibitor | 0.204 0.007 DB04456 0.072 0.041 DBMET02872 | DB04456 | |
| 0.097 | 0.163 | 0.124 | Hexokinase inhibitor | 0.124 0.112 DB04456 | DB04456 | |
| 0.149 | 0.243 | 0.192 | Vasodilator, peripheral | 0.192 0.186 DB04456 | DB04456 | |
| 0.017 | 0.138 | 0.138 | Carbonic anhydrase inhibitor | 0.138 0.018 DB04456 | DB04456 | |
| 0.081 | 0.398 | 0.218 | 15-Lipoxygenase inhibitor | 0.218 0.193 DB04456 | DB04456 | |
| 0.074 | 0.466 | 0.633 | Antibacterial | 0.54 0.031 DBMET02875 0.633 0.015 DBMET02874 | DBMET02874 | |
| 0.008 | 0.818 | 0.578 | Autotaxin inhibitor | 0.543 0.003 DB04456 0.172 0.006 DBMET02875 0.578 0.003 DBMET02872 0.551 0.003 DBMET02874 | DBMET02872 | |
| 0.004 | 0.979 | 0.864 | Thioredoxin glutathione reductase inhibitor | 0.833 0.004 DB04456 0.86 0.004 DBMET02875 0.864 0.004 DBMET02872 0.83 0.004 DBMET02874 | DBMET02872 | |
| 0 | 1 | 0.925 | Adenine nucleotide translocase inhibitor | 0.925 0 DB04456 0.772 0.001 DBMET02875 0.88 0 DBMET02872 0.772 0.001 DBMET02874 | DB04456 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |